MetLife Investment Management’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Buy |
81,505
+639
| +0.8% | +$1.74K | ﹤0.01% | 2134 |
|
|
2025
Q1 | $136K | Buy |
80,866
+53,208
| +192% | +$89.4K | ﹤0.01% | 2386 |
|
|
2024
Q4 | $45.1K | Sell |
27,658
-49,952
| -64% | -$81.4K | ﹤0.01% | 2748 |
|
|
2024
Q3 | $323K | Hold |
77,610
| – | – | ﹤0.01% | 2019 |
|
|
2024
Q2 | $424K | Buy |
77,610
+29,289
| +61% | +$160K | ﹤0.01% | 1815 |
|
|
2024
Q1 | $483K | Hold |
48,321
| – | – | ﹤0.01% | 1695 |
|
|
2023
Q4 | $197K | Hold |
48,321
| – | – | ﹤0.01% | 2256 |
|
|
2023
Q3 | $187K | Hold |
48,321
| – | – | ﹤0.01% | 2254 |
|
|
2023
Q2 | $288K | Hold |
48,321
| – | – | ﹤0.01% | 2041 |
|
|
2023
Q1 | $158K | Hold |
48,321
| – | – | ﹤0.01% | 2358 |
|
|
2022
Q4 | $191K | Hold |
48,321
| – | – | ﹤0.01% | 2275 |
|
|
2022
Q3 | $290K | Hold |
48,321
| – | – | ﹤0.01% | 2048 |
|
|
2022
Q2 | $311K | Hold |
48,321
| – | – | ﹤0.01% | 1994 |
|
|
2022
Q1 | $399K | Buy |
48,321
+17,543
| +57% | +$145K | ﹤0.01% | 1920 |
|
|
2021
Q4 | $476K | Hold |
30,778
| – | – | ﹤0.01% | 1532 |
|
|
2021
Q3 | $693K | Buy |
30,778
+19,193
| +166% | +$432K | 0.01% | 1337 |
|
|
2021
Q2 | $228K | Buy |
+11,585
| New | +$228K | ﹤0.01% | 2082 |
|